Literature DB >> 29064777

Mother of Berries, ACDC, or Chocolope: Examination of the Strains Used by Medical Cannabis Patients in New England.

Brian J Piper1.   

Abstract

Medical marijuana patients often believe that specific strains are more efficacious at treating their conditions. The goals of this investigation were to determine: (1) how many strains of cannabis are there; (2) which strains are used by medical cannabis (MC) patients; and (3) are there any differences in the strains used by patient condition? Study I involved quantifying the number of strains listed in the online database leafly.com and categorizing these by whether the strain name included a gustatory component. MC patients (N = 455) from New England completed an anonymous online survey about their medical history and strain preferences in Study II. There were 1,987 strains listed. Hybrids were significantly more likely than Cannabis indica strains to have a gustatory title. Strain preferences were highly state/dispensary specific with one-fifth of MC patients in Maine preferring Mother of Berries (M.O.B., 21.5%). Many respondents mentioned that they had developed a time-dependent pattern with sativa use during the day and an indica for nighttime use and for improving sleep. There is some general consistency across dispensaries in that hybrid strains and C. indica were most common. Further longitudinal and controlled investigations are necessary to identify the strains that are most efficacious for specific conditions.

Entities:  

Keywords:  Botany; chronic pain; marijuana; post-traumatic stress disorder

Mesh:

Substances:

Year:  2017        PMID: 29064777      PMCID: PMC6275121          DOI: 10.1080/02791072.2017.1390179

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  19 in total

1.  Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing.

Authors:  Jeffrey C Raber; Sytze Elzinga; Charles Kaplan
Journal:  J Toxicol Sci       Date:  2015-12       Impact factor: 2.196

Review 2.  Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

Authors:  S Agurell; M Halldin; J E Lindgren; A Ohlsson; M Widman; H Gillespie; L Hollister
Journal:  Pharmacol Rev       Date:  1986-03       Impact factor: 25.468

3.  How will pot legalization affect medical marijuana?

Authors:  Roger Collier
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

4.  The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.

Authors:  Steven Davenport; Bryce Pardo
Journal:  Int J Drug Policy       Date:  2016-09-03

Review 5.  Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Authors:  Ethan B Russo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 6.  Chemical constituents of marijuana: the complex mixture of natural cannabinoids.

Authors:  Mahmoud A Elsohly; Desmond Slade
Journal:  Life Sci       Date:  2005-09-30       Impact factor: 5.037

Review 7.  The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.

Authors:  Alice Mead
Journal:  Epilepsy Behav       Date:  2017-02-04       Impact factor: 2.937

8.  Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.

Authors:  Brian J Piper; Rebecca M DeKeuster; Monica L Beals; Catherine M Cobb; Corey A Burchman; Leah Perkinson; Shayne T Lynn; Stephanie D Nichols; Alexander T Abess
Journal:  J Psychopharmacol       Date:  2017-04-04       Impact factor: 4.153

Review 9.  A user's guide to cannabinoid therapies in oncology.

Authors:  V Maida; P J Daeninck
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

10.  The Genetic Structure of Marijuana and Hemp.

Authors:  Jason Sawler; Jake M Stout; Kyle M Gardner; Darryl Hudson; John Vidmar; Laura Butler; Jonathan E Page; Sean Myles
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

View more
  6 in total

1.  Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis.

Authors:  Assad Hayat; Brian J Piper
Journal:  J Psychoactive Drugs       Date:  2019-12-07

2.  Differences in cannabis use characteristics, routines, and reasons for use among individuals with and without a medical cannabis card.

Authors:  Benjamin L Berey; Elizabeth R Aston; Nioud Mulugeta Gebru; Jennifer E Merrill
Journal:  Exp Clin Psychopharmacol       Date:  2022-01-13       Impact factor: 3.492

Review 3.  Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug.

Authors:  Shiri Procaccia; Gil Moshe Lewitus; Carni Lipson Feder; Anna Shapira; Paula Berman; David Meiri
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

4.  An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample.

Authors:  Nirushi Kuhathasan; Luciano Minuzzi; James MacKillop; Benicio N Frey
Journal:  BMC Psychiatry       Date:  2022-04-28       Impact factor: 3.630

Review 5.  Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?

Authors:  Guido K W Frank
Journal:  Expert Opin Pharmacother       Date:  2020-04-13       Impact factor: 3.889

Review 6.  The importance of psychology for shaping legal cannabis regulation.

Authors:  Jacob T Borodovsky; Michael J Sofis; Richard A Grucza; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-21       Impact factor: 3.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.